---
title: "RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298667187.md"
description: "RBC Capital analyst Trung Huynh maintained a Buy rating on Johnson & Johnson (JNJ) with a $287 price target. The stock closed at $267.08. Huynh, known for his strong track record, covers the healthcare sector. Additionally, HSBC also issued a Buy rating for JNJ with a higher target of $320. Overall analyst consensus remains a Strong Buy, with an average target of $287.59, indicating significant upside potential."
datetime: "2026-09-11T01:45:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298667187.md)
  - [en](https://longbridge.com/en/news/298667187.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298667187.md)
generator: "portal-rs"
---

# RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

RBC Capital analyst Trung Huynh maintained a Buy rating on Johnson & Johnson on September 9 and set a price target of $287.00. The company’s shares closed yesterday at $267.08.

Huynh covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and AbbVie. According to TipRanks, Huynh has an average return of 22.2% and a 74.66% success rate on recommended stocks. 

Currently, the analyst consensus on Johnson & Johnson is a Strong Buy with an average price target of $287.59, a 7.68% upside from current levels. In a report released yesterday, HSBC also maintained a Buy rating on the stock with a $320.00 price target.

### Related Stocks

- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [HSBA.UK](https://longbridge.com/en/quote/HSBA.UK.md)
- [00005.HK](https://longbridge.com/en/quote/00005.HK.md)
- [HSBC.US](https://longbridge.com/en/quote/HSBC.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [DTIW.SG](https://longbridge.com/en/quote/DTIW.SG.md)

## Related News & Research

- [Johnson & Johnson (JNJ) Posts PAPILLON Survival Data, Is The Stock Fully Priced?](https://longbridge.com/en/news/298918543.md)
- [DBS Sticks to Their Hold Rating for Johnson & Johnson (JNJ)](https://longbridge.com/en/news/298756159.md)
- [Johnson & Johnson $JNJ Shares Sold by B. Metzler seel. Sohn & Co. AG](https://longbridge.com/en/news/298796355.md)
- [MW Advisory LLC Takes $1.13 Million Position in Johnson & Johnson $JNJ](https://longbridge.com/en/news/298883462.md)
- [Proficio Capital Partners LLC Boosts Position in Johnson & Johnson $JNJ](https://longbridge.com/en/news/298702042.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**